Catalyst Wire Dossier Catalyst Wire Dossier

MEM 3454

· Memory Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MEM 3454, covering 2008-05-06 to 2008-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia [Phase 2]

See pricing